سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Breast Cancer in Young Women: A Clinicopathological Hospital-based Descriptive Study from Kurdistan, Iraq

Publish Year: 1400
Type: Journal paper
Language: English
View: 118

This Paper With 6 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_MISJ-12-1_014

Index date: 16 November 2023

Breast Cancer in Young Women: A Clinicopathological Hospital-based Descriptive Study from Kurdistan, Iraq abstract

Background: Young women with breast cancer have been reported to present more aggressive clinical and pathological features, requiring more treatment options compared with older patients. Our objective was to investigate the clinicopathological features of breast cancer in our local young women. Method: We conducted an observational descriptive study on 100 young women (age ≤ 40) with breast cancer. The subjects were taken care of, at a single tertiary cancer facility, from mid-2007 to mid-2014. We reviewed the clinicopathological profiles and therapeutic strategies. Results: Ratio of breast cancer in young women was about 13% of all breast cancer patients. The mean age of the patients was 35 years ± 4SD. 56% of the patients had grade III tumors and 46% were in stage III. Hormonal receptors were positive in 70%, while HER2 was positive in 26%. 70% of the patients underwent modified radical mastectomy, 96% received chemotherapy, and 70% received radiotherapy and required hormonal therapy. Conclusion: This review showed that breast cancer in our local young women was largely diagnosed at advanced stages with more aggressive clinico-pathological features. Moreover, most of the patients received more aggressive treatment options. Therefore, physicians should pay a close attention to breast lumps in young women.

Breast Cancer in Young Women: A Clinicopathological Hospital-based Descriptive Study from Kurdistan, Iraq Keywords:

Breast Cancer in Young Women: A Clinicopathological Hospital-based Descriptive Study from Kurdistan, Iraq authors

Ahmed Ahmed

Department of Medical Oncology, Anbar Cancer Center, Anbar, Iraq

Anwar Sheikha

Department of Hematology, Hiwa Cancer Hospital, Sulaimani, Iraq

Hazha Abdulla

Department of Medical Oncology, Hiwa Cancer Hospital, Sulaimani, Iraq

Kamal Ahmed

Department of General Surgery, College of Medicine, University of Sulaimani, Sulaimani, Iraq

Layth Mula-Hussain

Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada